2015 Pharmaceutical Market Excellence Awards

Winner Category: “Rare Diseases and Orphan Drugs”

For the IPF Digital Initiative – a combination of several customer and patient-centric education and support programmes developed by infill healthcare communication for Boehringer Ingelheim GmbH. Judges’ comment: “Boehringer Ingelheim carried out detailed research into this rare and fatal disease and raised awareness amongst HCPs. This digital approach shared real-life patient cases online and had excellent view rates. A small team implemented an impressive campaign.”